Mary Piotrowski

Concentration-Dependent Modulation of Amyloid-β in Vivo and in Vitro Using the γ-Secretase Inhibitor, LY-450139

Thomas A. Lanz, Michael J. Karmilowicz, Kathleen M. Wood et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 133 citations

Medicine, Neuroscience, Pharmacology +13

Quantitative Prediction of Human Renal Clearance and Drug-Drug Interactions of Organic Anion Transporter Substrates Using In Vitro Transport Data: A Relative Activity Factor Approach

Sumathy Mathialagan, Mary Piotrowski, David A. Tess et al. · Drug Metabolism and Disposition · 2017 · 128 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Discovery, SAR, and Pharmacokinetics of a Novel 3-Hydroxyquinolin-2(1<i>H</i>)-one Series of Potent<scp>d</scp>-Amino Acid Oxidase (DAAO) Inhibitors

Allen J. Duplantier, Stacey L. Becker, Michael J. Bohanon et al. · Journal of Medicinal Chemistry · 2009 · 110 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Quantitative assessment of the contribution of sodium‐dependent taurocholate co‐transporting polypeptide (NTCP) to the hepatic uptake of rosuvastatin, pitavastatin and fluvastatin

Yi‐An Bi, Xi Qiu, Charles J. Rotter et al. · Biopharmaceutics & Drug Disposition · 2013 · 83 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Modulation of NMDA receptor function by inhibition of d-amino acid oxidase in rodent brain

Christine A. Strick, Cheryl Li, Liam Scott et al. · Neuropharmacology · 2011 · 40 citations

Life Sciences, Neurobiology, Neuroscience +14